Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Roche Holding Ltd.    RO   CH0012032113

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Income Statement Evolution
Roche Holding Ltd. : Income Statement Evolution
Annual Income Statement Data
Actuals in M CHF Estimates in M CHF
Fiscal Period December 201020112012201320142015
Sales47 47342 53145 49947 66349 58751 589
Operating income (EBITDA)18 51716 93319 04020 08221 10422 182
Operating profit (EBIT)16 59115 14917 16017 65918 54319 621
Pre-Tax Profit (EBT)11 21111 88512 32315 93217 06918 031
Net income8 6669 3439 53912 33813 38414 320
EPS ( CHF)10,111,011,214,315,616,8
Dividend per Share ( CHF)6,606,807,357,918,589,35
Yield2,63%2,71%2,93%3,15%3,42%3,73%
Announcement Date02/02/2011
06:13am		02/01/2012
06:28am		01/30/2013
06:15am		---
Finances - Leverage
Roche Holding Ltd. : Finances - Leverage
Actuals in M CHF Estimates in M CHF
Fiscal Period December 201020112012201320142015
Debt19 15715 56610 5995 545796-
Finance-----3 832
Operating income (EBITDA)18 51716 93319 04020 08221 10422 182
Leverage
(Debt/EBITDA)		1,03x0,92x0,56x0,28x0,04x-
Capital Expenditure2 6711 9592 1712 4692 4942 472
Book Value Per Share (BVPS)11,1  CHF14,3  CHF17,1  CHF25,1  CHF32,3  CHF40,0  CHF
Cash Flow per Share16,7  CHF15,2  CHF17,6  CHF17,7  CHF18,9  CHF20,7  CHF
Announcement Date02/02/2011
06:13am		02/01/2012
06:28am		01/30/2013
06:15am		---
Balance Sheet Analysis
Roche Holding Ltd. : Balance Sheet Analysis
Assessed data source :
© 2013 Thomson Reuters
Advertisement
Financial Ratios

Size 2013e 2014e
Capitalization 217 185 M CHF -
Company Value 222 730 M CHF 217 981 M CHF
Valuation 2013e 2014e
PER (Price / EPS) 17,6x 16,0x
Capitalization / Revenue 4,56x 4,38x
EV / Revenue 4,67x 4,40x
EV / EBITDA 11,1x 10,3x
Yield (DPS / Price) 3,15% 3,42%
Profitability 2013e 2014e
Operating Margin (EBIT / Sales) 37,0% 37,4%
operating laverage (Delta EBIT / Delta Sales) 0,61x 1,24x
Net Margin (Net Profit / Revenue) 25,9% 27,0%
ROA (Net Profit / Asset) 19,2% 19,4%
ROE (Net Profit / Equities) 67,5% 54,1%
Rate of Dividend 55,3% 54,8%
Balance Sheet Analysis 2013e 2014e
CAPEX / Sales   5,18% 5,03%
Cash Flow / Sales (Taux d'autofinancement) 32,0% 32,9%
Capital Intensity (Assets / Sales) 1,35x 1,39x
Financial Leverage (Net Debt / EBITDA) 0,28x 0,04x
Price Earning Ratio
Roche Holding Ltd. : Price Earning Ratio
EPS & Dividend
Roche Holding Ltd. : EPS Dividend
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Copyright © 2013 Surperformance. All rights reserved.